Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
RHHBY

Roche

$0.00

(0.00%)

, ONCE

Spark Therapeutics

$111.40

0.73 (0.66%)

05:10
04/26/19
04/26
05:10
04/26/19
05:10
Hot Stocks
Roche, Spark Therapeutics withdraw, refile premerger notification »

Roche (RHHBY) and Spark…

RHHBY

Roche

$0.00

(0.00%)

ONCE

Spark Therapeutics

$111.40

0.73 (0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 03

    May

  • 04

    May

  • 28

    May

  • 31

    May

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 02

    Sep

  • 04

    Nov

Tuesday
RHHBY

Roche

$0.00

(0.00%)

04:55
04/23/19
04/23
04:55
04/23/19
04:55
Conference/Events
Roche management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 03

    May

  • 04

    May

  • 28

    May

  • 31

    May

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 02

    Sep

  • 04

    Nov

Monday
IONS

Ionis Pharmaceuticals

$73.07

0.41 (0.56%)

, RHHBY

Roche

$0.00

(0.00%)

08:51
04/22/19
04/22
08:51
04/22/19
08:51
Recommendations
Ionis Pharmaceuticals, Roche analyst commentary at BMO Capital »

Ionis Pharmaceuticals…

IONS

Ionis Pharmaceuticals

$73.07

0.41 (0.56%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 03

    May

  • 04

    May

  • 06

    May

  • 14

    May

  • 28

    May

  • 31

    May

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 02

    Sep

  • 04

    Nov

Over a week ago
RHHBY

Roche

$0.00

(0.00%)

13:54
04/18/19
04/18
13:54
04/18/19
13:54
Conference/Events
Roche management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 03

    May

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 02

    Sep

  • 04

    Nov

IONS

Ionis Pharmaceuticals

$71.20

-12.06 (-14.48%)

, RHHBY

Roche

$0.00

(0.00%)

13:50
04/17/19
04/17
13:50
04/17/19
13:50
Recommendations
Ionis Pharmaceuticals, Roche analyst commentary at Wells Fargo »

Ionis pullback on Roche…

IONS

Ionis Pharmaceuticals

$71.20

-12.06 (-14.48%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

  • 03

    May

  • 06

    May

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 02

    Sep

  • 04

    Nov

IONS

Ionis Pharmaceuticals

$71.52

-11.74 (-14.10%)

, RHHBY

Roche

$0.00

(0.00%)

13:41
04/17/19
04/17
13:41
04/17/19
13:41
Recommendations
Ionis Pharmaceuticals, Roche analyst commentary at Wells Fargo »

Wells says Ionis weakness…

IONS

Ionis Pharmaceuticals

$71.52

-11.74 (-14.10%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

  • 03

    May

  • 06

    May

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 02

    Sep

  • 04

    Nov

RHHBY

Roche

$0.00

(0.00%)

05:45
04/17/19
04/17
05:45
04/17/19
05:45
Earnings
Roche raises FY19 revenue guidance to mid-single digit growth »

Sales are now expected to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 02

    Sep

  • 04

    Nov

RHHBY

Roche

$0.00

(0.00%)

05:45
04/17/19
04/17
05:45
04/17/19
05:45
Earnings
Roche reports Q1 revenue CHF 14.83B vs. CHF 13.58B last year »

Commenting on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 02

    Sep

  • 04

    Nov

ALC

Alcon

$57.23

-1.15 (-1.97%)

, AAPL

Apple

$199.55

-0.04 (-0.02%)

11:20
04/10/19
04/10
11:20
04/10/19
11:20
On The Fly
Apple downgrade, Tesla initiation among today's top analyst calls »

Check out today's top…

ALC

Alcon

$57.23

-1.15 (-1.97%)

AAPL

Apple

$199.55

-0.04 (-0.02%)

TSLA

Tesla

$275.35

3.22 (1.18%)

GILD

Gilead

$67.33

1.24 (1.88%)

JWN

Nordstrom

$44.59

0.44 (1.00%)

UA

Under Armour

$19.13

0.42 (2.24%)

UAA

Under Armour

$21.21

0.5 (2.41%)

NVS

Novartis

$82.08

-1.32 (-1.58%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Apr

  • 16

    Apr

  • 17

    Apr

  • 22

    Apr

  • 24

    Apr

  • 30

    Apr

  • 02

    May

  • 08

    May

  • 09

    May

  • 09

    May

  • 18

    May

  • 03

    Jun

  • 18

    Aug

  • 19

    Aug

  • 02

    Sep

  • 04

    Nov

NVS

Novartis

$83.40

-11.515 (-12.13%)

, RHHBY

Roche

$0.00

(0.00%)

05:21
04/10/19
04/10
05:21
04/10/19
05:21
Downgrade
Novartis, Roche rating change at Morgan Stanley »

Novartis downgraded to…

NVS

Novartis

$83.40

-11.515 (-12.13%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Apr

  • 17

    Apr

  • 24

    Apr

  • 18

    Aug

  • 19

    Aug

  • 02

    Sep

  • 04

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.